Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1978 Sep;21(3):959–965. doi: 10.1128/iai.21.3.959-965.1978

Polymorphonuclear cell function in the various polar types of leprosy and erythema nodosum leprosum.

R Sher, R Anderson, A Glover, A A Wadee
PMCID: PMC422090  PMID: 711343

Abstract

Polymorphonuclear leukocyte motility, both in vivo and in vitro, and reduction of Nitro Blue Tetrazolium was studied in tuberculoid and lepromatous leprosy patients and a group of lepromatous patients with erythema nodosum leprosum (ENL). A profound defect in random migration, chemotaxis, and chemokinesis was found in lepromatous patients with and without complicating ENL, and marked depletion of skin window migration confirmed these in vitro findings. Tuberculoid patients exhibited a mild defect in polymorphonuclear leukocyte motility. Serum inhibitors of normal polymorphonuclear leukocyte chemotaxis were found in all types of leprosy, but sera from lepromatous and ENL patients were most inhibitory. Resting levels of Nitro Blue Tetrazolium reduction were normal in all three groups. Reconstitution of polymorphonuclear leukocyte cells from normal and ENL patients with ENL serum, however, showed increased Nitro Blue Tetrazolium reduction well above the normal range, whereas reconstitution with normal, lepromatous, and tuberculoid sera failed to increase Nitro Blue Tetrazolium reduction above the normal values.

Full text

PDF
963

Images in this article

963Image
on p.963
963Image
on p.963

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson R., Rabson A. R., Sher R., Koornhof H. J. Defective neutrophil motility in children with measles. J Pediatr. 1976 Jul;89(1):27–32. doi: 10.1016/s0022-3476(76)80921-3. [DOI] [PubMed] [Google Scholar]
  2. Barbieri T. A., Correa W. M. Human macrophage culture. The leprosy prognostic test (LPT). Int J Lepr Other Mycobact Dis. 1967 Jul-Sep;35(3):377–381. [PubMed] [Google Scholar]
  3. Bullock W. E., Jr, Ho M. F., Chen M. J. Quantitative and qualitative studies of the local cellular exudative response in leprosy. J Reticuloendothel Soc. 1974 Nov;16(5):259–268. [PubMed] [Google Scholar]
  4. Drutz D. J., Cline M. J., Levy L. Leukocyte antimicrobial function in patients with leprosy. J Clin Invest. 1974 Feb;53(2):380–386. doi: 10.1172/JCI107570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Frei P. C., Baisero M. H., Ochsner M. Chemotaxis of human polymorphonuclears in vitro. Critical study of clinical interpretations. Antibiot Chemother (1971) 1974;19:350–361. doi: 10.1159/000395440. [DOI] [PubMed] [Google Scholar]
  6. Godal T. Cellular immune defect in lepromatous leprosy. Ethiop Med J. 1973 Apr;11(2):190–193. [PubMed] [Google Scholar]
  7. Goihman-Yahr M., Rodríguez-Ochoa G., Aranzazu N., Convit J. Polymorphonuclear activation in leprosy. I. Spontaneous and endotoxin-stimulated reduction of nitroblue tetrazolium: effects of serum and plasma on endotoxin-induced activation. Clin Exp Immunol. 1975 May;20(2):257–264. [PMC free article] [PubMed] [Google Scholar]
  8. Han S. H., Weiser R. S., Lin Y. C. Transformation of leprous lymphocytes by leprolin, tuberculin and phytohemagglutinin. Int J Lepr Other Mycobact Dis. 1971 Oct-Dec;39(4):789–795. [PubMed] [Google Scholar]
  9. Miller M. E., Oski F. A., Harris M. B. Lazy-leucocyte syndrome. A new disorder of neutrophil function. Lancet. 1971 Apr 3;1(7701):665–669. doi: 10.1016/s0140-6736(71)92679-1. [DOI] [PubMed] [Google Scholar]
  10. Moran C. J., Ryder G., Turk J. L., Waters M. F. Evidence for circulating immune complexes in lepromatous leprosy. Lancet. 1972 Sep 16;2(7777):572–573. doi: 10.1016/s0140-6736(72)91962-9. [DOI] [PubMed] [Google Scholar]
  11. Mowat A. G., Baum J. Polymorphonuclear leucocyte chemotaxis in patients with bacterial infections. Br Med J. 1971 Sep 11;3(5775):617–619. doi: 10.1136/bmj.3.5775.617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. REBUCK J. W., CROWLEY J. H. A method of studying leukocytic functions in vivo. Ann N Y Acad Sci. 1955 Mar 24;59(5):757–805. doi: 10.1111/j.1749-6632.1955.tb45983.x. [DOI] [PubMed] [Google Scholar]
  13. Ridley D. S., Jopling W. H. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis. 1966 Jul-Sep;34(3):255–273. [PubMed] [Google Scholar]
  14. SBARRA A. J., KARNOVSKY M. L. The biochemical basis of phagocytosis. I. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes. J Biol Chem. 1959 Jun;234(6):1355–1362. [PubMed] [Google Scholar]
  15. Sher R., Anderson R., Rabson A. R., Koornhof H. J. Standardisation of the nitro-blue tetrazolium test and factors affecting its clinical application. S Afr Med J. 1974 Feb 9;48(6):209–212. [PubMed] [Google Scholar]
  16. Sher R., Holm G., Kok S. H., Koornhof H. J., Glover A. T and CR+ lymphocyte profile in leprosy and the effect of treatment. Infect Immun. 1976 Jan;13(1):31–35. doi: 10.1128/iai.13.1.31-35.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Sher R., Mackay M. E., Macnab G. M., Kok S. H., Koornhof H. J. Hepatitis B antigen, hepatitis B antibody, and subtypes in leprosy. Infect Immun. 1977 Jul;17(1):1–3. doi: 10.1128/iai.17.1.1-3.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Van Epps D. E., Palmer D. L., Williams R. C., Jr Characterization of serum inhibitors of neutrophil chemotaxis associated with anergy. J Immunol. 1974 Jul;113(1):189–200. [PubMed] [Google Scholar]
  19. Waldorf D. S., Sheagren J. N., Trautman J. R., Block J. B. Impaired delayed hypersensitivity in patients with lepromatous leprosy. Lancet. 1966 Oct 8;2(7467):773–776. doi: 10.1016/s0140-6736(66)90366-7. [DOI] [PubMed] [Google Scholar]
  20. Ward P. A., Goralnick S., Bullock W. E. Defective leukotaxis in patients with lepromatous leprosy. J Lab Clin Med. 1976 Jun;87(6):1025–1032. [PubMed] [Google Scholar]
  21. Zigmond S. H., Hirsch J. G. Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor. J Exp Med. 1973 Feb 1;137(2):387–410. doi: 10.1084/jem.137.2.387. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES